Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	MHC class Ib protein binding	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	5.10e-07	16	84	4	GO:0023029
GeneOntologyMolecularFunction	MHC class Ib receptor activity	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	1.08e-06	19	84	4	GO:0032394
GeneOntologyMolecularFunction	dopamine neurotransmitter receptor activity, coupled via Gs	DRD1 DRD5	1.75e-05	2	84	2	GO:0001588
GeneOntologyMolecularFunction	MHC class I receptor activity	KIR2DS5 KIR3DL1 KIR3DS1	5.60e-05	18	84	3	GO:0032393
GeneOntologyMolecularFunction	immune receptor activity	KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	6.94e-05	165	84	6	GO:0140375
GeneOntologyMolecularFunction	MHC protein binding	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	1.04e-04	58	84	4	GO:0042287
GeneOntologyMolecularFunction	microtubule plus-end binding	CLIP4 CLASP1 CLASP2	1.04e-04	22	84	3	GO:0051010
GeneOntologyMolecularFunction	dopamine neurotransmitter receptor activity	DRD1 DRD5	1.73e-04	5	84	2	GO:0004952
GeneOntologyMolecularFunction	transcription coregulator binding	MYC STK36 PER2 NFATC1 FOS	3.12e-04	140	84	5	GO:0001221
GeneOntologyMolecularFunction	dopamine binding	DRD1 DRD5	3.62e-04	7	84	2	GO:0035240
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	MYC PER2 NFATC1 PIK3R1 FOS PRDM5 SPEN MEF2C PASD1	7.52e-04	582	84	9	GO:0140297
GeneOntologyMolecularFunction	dystroglycan binding	CLASP1 CLASP2	1.12e-03	12	84	2	GO:0002162
GeneOntologyMolecularFunction	inhibitory MHC class I receptor activity	KIR2DS5 KIR3DL1	1.12e-03	12	84	2	GO:0032396
GeneOntologyMolecularFunction	transcription factor binding	MYC STK36 PER2 NFATC1 PIK3R1 FOS PRDM5 SPEN MEF2C PASD1	1.22e-03	753	84	10	GO:0008134
GeneOntologyMolecularFunction	catecholamine binding	DRD1 DRD5	1.32e-03	13	84	2	GO:1901338
GeneOntologyBiologicalProcess	microtubule depolymerization	CLASP1 NAV3 NCKAP5 CLASP2 NCKAP5L	8.68e-06	66	87	5	GO:0007019
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	PIK3R1 KIR2DS2 IRF7 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 MEF2C	1.02e-05	615	87	12	GO:0002764
GeneOntologyBiologicalProcess	nonassociative learning	DRD1 DRD5 KALRN	2.01e-05	13	87	3	GO:0046958
GeneOntologyBiologicalProcess	negative regulation of circadian rhythm	DRD1 PER2 PASD1	3.90e-05	16	87	3	GO:0042754
GeneOntologyBiologicalProcess	epithelial cell proliferation involved in renal tubule morphogenesis	MTSS1 MEF2C	1.05e-04	4	87	2	GO:2001013
GeneOntologyBiologicalProcess	positive regulation of basement membrane assembly involved in embryonic body morphogenesis	CLASP1 CLASP2	1.74e-04	5	87	2	GO:1904261
GeneOntologyBiologicalProcess	regulation of basement membrane assembly involved in embryonic body morphogenesis	CLASP1 CLASP2	1.74e-04	5	87	2	GO:1904259
GeneOntologyBiologicalProcess	operant conditioning	DRD1 PDE8B	1.74e-04	5	87	2	GO:0035106
GeneOntologyBiologicalProcess	negative regulation of wound healing, spreading of epidermal cells	CLASP1 CLASP2	1.74e-04	5	87	2	GO:1903690
GeneOntologyBiologicalProcess	basement membrane assembly involved in embryonic body morphogenesis	CLASP1 CLASP2	1.74e-04	5	87	2	GO:2001197
GeneOntologyBiologicalProcess	sensitization	DRD1 DRD5	1.74e-04	5	87	2	GO:0046960
GeneOntologyBiologicalProcess	supramolecular fiber organization	CLIP4 ESPN CLASP1 PIK3R1 FURIN MTSS1 NAV3 NCKAP5 CLASP2 NCKAP5L PREX1 MEF2C CAP1	1.80e-04	957	87	13	GO:0097435
GeneOntologyBiologicalProcess	protein-containing complex disassembly	MYC PER2 CLASP1 NAV3 NCKAP5 CLASP2 NCKAP5L	2.31e-04	291	87	7	GO:0032984
GeneOntologyBiologicalProcess	NMDA selective glutamate receptor signaling pathway	KALRN MEF2C	2.61e-04	6	87	2	GO:0098989
GeneOntologyBiologicalProcess	conditioned taste aversion	DRD1 FOS	2.61e-04	6	87	2	GO:0001661
GeneOntologyBiologicalProcess	cellular component disassembly	MYC PER2 CLASP1 PIK3R1 FURIN PRKAA1 NAV3 NCKAP5 CLASP2 NCKAP5L	2.69e-04	617	87	10	GO:0022411
GeneOntologyBiologicalProcess	protein depolymerization	CLASP1 NAV3 NCKAP5 CLASP2 NCKAP5L	3.61e-04	144	87	5	GO:0051261
GeneOntologyBiologicalProcess	skeletal muscle tissue development	MYC HOXD10 FOS PRKAA1 PHOX2B MEF2C	3.64e-04	223	87	6	GO:0007519
GeneOntologyCellularComponent	microtubule end	CLIP4 CLASP1 NAV3 NCKAP5 CLASP2 NCKAP5L	1.16e-08	38	88	6	GO:1990752
GeneOntologyCellularComponent	microtubule plus-end	CLIP4 CLASP1 NCKAP5 CLASP2 NCKAP5L	1.07e-07	28	88	5	GO:0035371
GeneOntologyCellularComponent	transcription repressor complex	MYC PER2 HOXD10 SPEN PASD1	3.32e-05	87	88	5	GO:0017053
GeneOntologyCellularComponent	Cry-Per complex	PER2 PASD1	5.24e-05	3	88	2	GO:1990512
GeneOntologyCellularComponent	cortical microtubule cytoskeleton	CLASP1 CLASP2	1.74e-04	5	88	2	GO:0030981
GeneOntologyCellularComponent	early endosome membrane	EPS15 ZFYVE16 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	2.75e-04	212	88	6	GO:0031901
GeneOntologyCellularComponent	basal cortex	CLASP1 CLASP2	3.63e-04	7	88	2	GO:0045180
GeneOntologyCellularComponent	ciliary membrane	EPS15 DRD1 DRD5 BBS9	7.83e-04	98	88	4	GO:0060170
GeneOntologyCellularComponent	early endosome	EPS15 ZFYVE16 FURIN APOB KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	9.53e-04	481	88	8	GO:0005769
GeneOntologyCellularComponent	cell cortex	CLIP4 HMCN2 CLASP1 CLASP2 FRYL CAP1 PDZD4	9.70e-04	371	88	7	GO:0005938
GeneOntologyCellularComponent	endosome membrane	EPS15 ZFYVE16 FURIN IRF7 APOB KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	9.70e-04	602	88	9	GO:0010008
Domain	IG	HMCN2 KALRN MPZL1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 SEMA4G	5.47e-08	421	85	13	SM00409
Domain	Ig_sub	HMCN2 KALRN MPZL1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 SEMA4G	5.47e-08	421	85	13	IPR003599
Domain	ig	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	2.04e-07	190	85	9	PF00047
Domain	Immunoglobulin	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	2.04e-07	190	85	9	IPR013151
Domain	Ig-like_dom	HMCN2 KALRN MPZL1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 SEMA4G	4.23e-07	503	85	13	IPR007110
Domain	IG_LIKE	HMCN2 KALRN MPZL1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 SEMA4G	2.20e-06	491	85	12	PS50835
Domain	Ig-like_fold	HMCN2 NFATC1 KALRN MPZL1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 SEMA4G	3.38e-06	706	85	14	IPR013783
Domain	NCKAP5_C	NCKAP5 NCKAP5L	2.05e-05	2	85	2	IPR032769
Domain	Nckap5l	NCKAP5 NCKAP5L	2.05e-05	2	85	2	IPR026163
Domain	NCKAP5	NCKAP5 NCKAP5L	2.05e-05	2	85	2	PF15246
Domain	-	NFATC1 KALRN MPZL1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1 SEMA4G	4.45e-05	663	85	12	2.60.40.10
Domain	CLASP_N	CLASP1 CLASP2	1.22e-04	4	85	2	PF12348
Domain	CLASP_N_dom	CLASP1 CLASP2	1.22e-04	4	85	2	IPR024395
Domain	Dopamine_rcpt	DRD1 DRD5	2.03e-04	5	85	2	IPR000929
Domain	Peptidase_S8_Asp-AS	PCSK2 FURIN	3.03e-04	6	85	2	IPR023827
Domain	-	PCSK2 FURIN DCBLD1 SUCO	3.42e-04	73	85	4	2.60.120.260
Domain	PAS	PER2 PDE8B PASD1	4.10e-04	32	85	3	SM00091
Domain	PrprotnconvertsP	PCSK2 FURIN	4.24e-04	7	85	2	IPR002884
Domain	P_proprotein	PCSK2 FURIN	4.24e-04	7	85	2	PF01483
Domain	S8_pro-domain	PCSK2 FURIN	4.24e-04	7	85	2	IPR032815
Domain	-	PCSK2 FURIN	4.24e-04	7	85	2	3.30.70.850
Domain	S8_pro-domain	PCSK2 FURIN	4.24e-04	7	85	2	PF16470
Domain	PAS	PER2 PDE8B PASD1	4.92e-04	34	85	3	IPR000014
Domain	PAS	PER2 PDE8B PASD1	4.92e-04	34	85	3	PS50112
Domain	Peptidase_S8_His-AS	PCSK2 FURIN	7.22e-04	9	85	2	IPR022398
Domain	Peptidase_S8_Ser-AS	PCSK2 FURIN	7.22e-04	9	85	2	IPR023828
Domain	Galactose-bd-like	PCSK2 FURIN DCBLD1 SUCO	8.92e-04	94	85	4	IPR008979
Domain	Peptidase_S8_subtilisin-rel	PCSK2 FURIN	9.00e-04	10	85	2	IPR015500
Domain	SUBTILASE_ASP	PCSK2 FURIN	9.00e-04	10	85	2	PS00136
Domain	SUBTILASE_HIS	PCSK2 FURIN	9.00e-04	10	85	2	PS00137
Domain	SUBTILASE_SER	PCSK2 FURIN	9.00e-04	10	85	2	PS00138
Domain	-	PCSK2 FURIN	1.10e-03	11	85	2	3.40.50.200
Domain	Peptidase_S8/S53_dom	PCSK2 FURIN	1.10e-03	11	85	2	IPR000209
Domain	Peptidase_S8	PCSK2 FURIN	1.10e-03	11	85	2	PF00082
Domain	HEAT	STK36 CLASP1 CLASP2	1.36e-03	48	85	3	PF02985
Domain	-	FBXO30 PDZRN4	1.80e-03	14	85	2	3.90.890.10
Domain	WH2	ESPN MTSS1	1.80e-03	14	85	2	SM00246
Domain	HEAT	STK36 CLASP1 CLASP2	2.34e-03	58	85	3	IPR000357
Domain	SIAH-type	FBXO30 PDZRN4	2.36e-03	16	85	2	IPR013323
Domain	WH2	ESPN MTSS1	2.36e-03	16	85	2	PF02205
Domain	Propept_inh	PCSK2 FURIN	2.66e-03	17	85	2	IPR009020
Domain	WH2_dom	ESPN MTSS1	4.06e-03	21	85	2	IPR003124
Domain	Znf_C2H2_jaz	GPATCH8 PRDM5	4.46e-03	22	85	2	IPR022755
Domain	zf-C2H2_jaz	GPATCH8 PRDM5	4.46e-03	22	85	2	PF12171
Domain	WH2	ESPN MTSS1	5.29e-03	24	85	2	PS51082
Domain	TRAF-like	FBXO30 PDZRN4	5.29e-03	24	85	2	IPR008974
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	NFATC1 PIK3R1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	4.94e-09	137	59	9	M5669
Pathway	REACTOME_DAP12_INTERACTIONS	PIK3R1 KIR2DS2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DS1	3.41e-08	46	59	6	M27151
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	7.60e-08	88	59	7	M16004
Pathway	REACTOME_DAP12_INTERACTIONS	PIK3R1 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	2.92e-06	54	59	5	MM14871
Pathway	REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING	CLASP1 CLASP2 CAP1	3.84e-06	8	59	3	M27351
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.50e-05	41	59	4	M13519
Pathway	PID_NOTCH_PATHWAY	MYC EPS15 FURIN SPEN	1.06e-04	59	59	4	M17
Pathway	BIOCARTA_GLEEVEC_PATHWAY	MYC PIK3R1 FOS	1.16e-04	23	59	3	MM1424
Pathway	BIOCARTA_GLEEVEC_PATHWAY	MYC PIK3R1 FOS	1.16e-04	23	59	3	M7897
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 IGKV3-20	1.38e-04	190	59	6	M8240
Pathway	REACTOME_DOPAMINE_RECEPTORS	DRD1 DRD5	1.71e-04	5	59	2	M27301
Pathway	REACTOME_DOPAMINE_RECEPTORS	DRD1 DRD5	1.71e-04	5	59	2	MM15007
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	NFATC1 POLR3E PIK3R1 FOS KIR2DS2 IRF7 APOB KIR2DS1 KIR2DS4 KIR2DS5 KIR3DS1 MEF2C IGKV3-20 CAP1	1.77e-04	1128	59	14	M1036
Pathway	WP_DELTANOTCH_SIGNALING_PATHWAY	PIK3R1 FURIN SPEN MEF2C	3.79e-04	82	59	4	MM15922
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	MYC FOS IRF7 MEF2C	3.79e-04	82	59	4	M2
Pathway	WP_HEPATITIS_B_INFECTION	MYC NFATC1 PIK3R1 FOS IRF7	4.15e-04	151	59	5	M39801
Pathway	BIOCARTA_IL2RB_PATHWAY	MYC PIK3R1 FOS	4.51e-04	36	59	3	MM1418
Pathway	BIOCARTA_IL2RB_PATHWAY	MYC PIK3R1 FOS	4.89e-04	37	59	3	M8615
Pathway	BIOCARTA_FCER1_PATHWAY	NFATC1 PIK3R1 FOS	5.72e-04	39	59	3	MM1397
Pathway	BIOCARTA_FCER1_PATHWAY	NFATC1 PIK3R1 FOS	5.72e-04	39	59	3	M1908
Pathway	WP_IL5_SIGNALING	MYC PIK3R1 FOS	6.16e-04	40	59	3	M39392
Pathway	WP_IL2_SIGNALING	MYC PIK3R1 FOS	7.12e-04	42	59	3	M39536
Pathway	BIOCARTA_TCR_PATHWAY	NFATC1 PIK3R1 FOS	7.12e-04	42	59	3	MM1504
Pathway	BIOCARTA_TCR_PATHWAY	NFATC1 PIK3R1 FOS	8.16e-04	44	59	3	M19784
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.89e-22	11	90	9	19664392
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	7.53e-22	12	90	9	20371502
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	7.53e-22	12	90	9	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	7.53e-22	12	90	9	19181658
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	2.44e-21	13	90	9	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	2.44e-21	13	90	9	19120281
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	2.44e-21	13	90	9	18687225
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	6.83e-21	14	90	9	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	6.83e-21	14	90	9	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	6.83e-21	14	90	9	15896204
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.70e-20	15	90	9	20082646
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.70e-20	15	90	9	19850842
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.70e-20	15	90	9	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.70e-20	15	90	9	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.70e-20	15	90	9	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.70e-20	15	90	9	19493232
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.70e-20	15	90	9	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.70e-20	15	90	9	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	18668235
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	19309280
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	20652381
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	18643961
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	20331834
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.88e-20	16	90	9	20210919
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	20650299
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	20483367
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	19169284
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	8.24e-20	17	90	9	19761533
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.64e-19	18	90	9	19630074
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.64e-19	18	90	9	19046302
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.64e-19	18	90	9	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.64e-19	18	90	9	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.64e-19	18	90	9	19846535
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	2.40e-19	11	90	8	18830515
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.12e-19	19	90	9	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.12e-19	19	90	9	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.12e-19	19	90	9	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.12e-19	19	90	9	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	5.66e-19	20	90	9	20193031
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	7.17e-19	12	90	8	20137308
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	9.88e-19	21	90	9	19861144
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.67e-18	22	90	9	20492596
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1	4.33e-18	14	90	8	19489269
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	4.33e-18	14	90	8	18945962
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5	4.89e-18	8	90	7	18681957
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	9.27e-18	15	90	8	17498266
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	1.85e-17	16	90	8	16403292
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1	2.19e-17	9	90	7	7749980
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	2.19e-17	9	90	7	8662091
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.31e-17	29	90	9	20082482
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	3.49e-17	17	90	8	19032228
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DS1	3.49e-17	17	90	8	20173784
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	6.26e-17	18	90	8	20200544
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	6.26e-17	18	90	8	20210918
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1	7.30e-17	10	90	7	12559621
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.79e-16	20	90	8	20426625
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	2.30e-16	35	90	9	19683555
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	4.80e-16	12	90	7	17490516
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4 KIR2DS5 KIR3DL1	1.77e-15	7	90	6	14607943
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4	1.77e-15	7	90	6	11169255
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1	7.07e-15	8	90	6	17200871
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1	2.12e-14	9	90	6	18340360
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DL2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	5.28e-14	10	90	6	21206914
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	1.04e-13	5	90	5	18755860
Pubmed	Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4	1.04e-13	5	90	5	10424431
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	1.04e-13	5	90	5	16112031
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DS1	6.21e-13	6	90	5	17882223
Pubmed	Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.	KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DS1	2.17e-12	7	90	5	9430220
Pubmed	A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1	5.77e-12	8	90	5	15730517
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DS1	5.77e-12	8	90	5	9430221
Pubmed	Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	4.19e-11	4	90	4	18632158
Pubmed	Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	4.19e-11	4	90	4	26542066
Pubmed	High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.	KIR2DL2 KIR2DL3 KIR3DL1 KIR3DS1	4.19e-11	4	90	4	19522772
Pubmed	[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	4.19e-11	4	90	4	18269867
Pubmed	Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	4.19e-11	4	90	4	23354323
Pubmed	KIR gene in ethnic and Mestizo populations from Mexico.	KIR2DL2 KIR2DS1 KIR2DS5 KIR3DS1	2.09e-10	5	90	4	16698429
Pubmed	Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.	KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1	2.09e-10	5	90	4	7716543
Pubmed	KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	2.09e-10	5	90	4	27893413
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS2 KIR2DS1 KIR2DS4 KIR2DS5	2.09e-10	5	90	4	19410616
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.	KIR2DS2 KIR2DS1 KIR3DL1 KIR3DS1	6.26e-10	6	90	4	20528243
Pubmed	Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	1.46e-09	7	90	4	12618911
Pubmed	Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	1.46e-09	7	90	4	26928464
Pubmed	Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	1.46e-09	7	90	4	15748957
Pubmed	Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.91e-09	8	90	4	20935224
Pubmed	Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.	KIR2DS2 KIR2DL1 KIR2DS1	1.68e-08	3	90	3	29549293
Pubmed	Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus.	KIR2DL2 KIR2DS5 KIR3DS1	1.68e-08	3	90	3	16698433
Pubmed	Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.	KIR2DS2 KIR2DL2 KIR2DL3	1.68e-08	3	90	3	30696053
Pubmed	Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.	KIR2DL1 KIR2DL3 KIR3DL1	1.68e-08	3	90	3	30698860
Pubmed	Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	1.68e-08	3	90	3	22960345
Interaction	KIR2DL2 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1 KIR3DS1	1.67e-09	13	87	5	int:KIR2DL2
Interaction	KIR3DL1 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1	2.25e-07	13	87	4	int:KIR3DL1
Interaction	KIR3DP1 interactions	KIR2DS2 KIR2DL1 KIR2DS5	3.10e-07	4	87	3	int:KIR3DP1
Interaction	KIR2DS2 interactions	KIR2DS2 KIR2DL2 KIR2DS1 KIR2DS5 KIR3DL1	5.22e-07	37	87	5	int:KIR2DS2
Interaction	KIR2DS3 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS5	1.49e-06	20	87	4	int:KIR2DS3
Interaction	CLIP4 interactions	CLIP4 CLASP1 PRKAA1 CLASP2	5.02e-05	47	87	4	int:CLIP4
Interaction	TMEM114 interactions	EPS15 EMP1	5.51e-05	3	87	2	int:TMEM114
Cytoband	19q13.4	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	5.78e-14	79	91	9	19q13.4
Cytoband	5q14	ZFYVE16 MEF2C	1.73e-04	10	91	2	5q14
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1	1.24e-18	18	60	9	620
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CD6 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	5.60e-06	394	60	9	471
GeneFamily	Dopamine receptors	DRD1 DRD5	1.08e-04	5	60	2	181
GeneFamily	Proprotein convertase subtilisin/kexin family	PCSK2 FURIN	3.84e-04	9	60	2	973
Coexpression	KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1	3.39e-10	49	90	7	M40909
Coexpression	TURJANSKI_MAPK7_TARGETS	MYC FOS MEF2C	1.36e-06	7	90	3	M11218
Coexpression	GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	4.23e-06	190	90	7	M4662
Coexpression	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP	PIK3R1 FOS RALGPS1 NKTR SARAF SERINC5 KAT6B	5.55e-06	198	90	7	M5293
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	MYC PIK3R1 SARAF SERINC5 GPATCH8 SPEN TGS1	5.55e-06	198	90	7	M6128
Coexpression	GSE22886_NAIVE_TCELL_VS_NKCELL_DN	CLASP1 ZFYVE16 FURIN CLASP2 FRYL KIR2DL1 KIR3DS1	5.55e-06	198	90	7	M4415
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	MYC PER2 CLASP1 NAV3 FRYL KAT6B SPEN SUCO	9.22e-06	300	90	8	M8702
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL	KIR2DL1 KIR2DL3 KIR3DL1	3.08e-05	18	90	3	M45763
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN	CLIP4 ZFYVE16 PIK3R1 FOS SYTL2 CATSPERB	4.89e-05	189	90	6	M8275
Coexpression	GSE45837_WT_VS_GFI1_KO_PDC_UP	PDE8B FURIN SYTL2 NKTR FAM135A IGKV3-20	5.82e-05	195	90	6	M9892
Coexpression	GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN	FURIN TMEM134 KIR2DS2 CATSPERB IRF7 KIR2DS5	5.82e-05	195	90	6	M5445
Coexpression	GSE3982_DC_VS_NEUTROPHIL_DN	PCSK2 GVINP1 MPZL1 CATSPERB IRF7 SPEN	6.16e-05	197	90	6	M5462
Coexpression	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP	PIK3R1 FOS RALGPS1 SARAF SERINC5 KAT6B	6.33e-05	198	90	6	M5289
Coexpression	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP	PIK3R1 FURIN CLASP2 GPATCH8 EMP1 PDZD4	6.51e-05	199	90	6	M8115
Coexpression	GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN	PIK3R1 SYTL2 MTSS1 NKTR SARAF EMP1	6.51e-05	199	90	6	M6576
Coexpression	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DS1	6.51e-05	199	90	6	M9885
Coexpression	GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP	FOS MACROD1 IRF7 SARAF TTC3 BAHCC1	6.51e-05	199	90	6	M7520
Coexpression	GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN	CLIP4 MACROD1 SARAF TTC3 SEMA4G BAHCC1	6.51e-05	199	90	6	M7510
Coexpression	GSE10325_CD4_TCELL_VS_MYELOID_UP	MYC CD6 GVINP1 POLR3E PIK3R1 KAT6B	6.51e-05	199	90	6	M3078
Coexpression	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	MYC MTSS1 PREX1	6.60e-05	23	90	3	M13910
Coexpression	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN	TCP11L2 HOXD10 PIK3R1 MTSS1 SARAF EMP1	6.69e-05	200	90	6	M8110
Coexpression	GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP	CD6 SYTL2 SARAF EMP1 BBS9 MEF2C	6.69e-05	200	90	6	M4579
Coexpression	GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN	MYC EPS15 ZFYVE16 FURIN IRF7 EMP1	6.69e-05	200	90	6	M7276
Coexpression	TURJANSKI_MAPK11_TARGETS	FOS MEF2C	1.16e-04	5	90	2	M2492
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	CLASP1 NAV3 FRYL KAT6B SUCO	1.46e-04	145	90	5	M1810
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MYC EPS15 CLASP1 ZFYVE16 NAV3 CLASP2 FRYL GPATCH8 KAT6B SPEN SUCO	1.68e-04	856	90	11	M4500
Coexpression	LI_INDUCED_T_TO_NATURAL_KILLER_UP	FURIN SYTL2 KIR2DL1 KIR2DL3 EMP1 KIR2DS4 KIR3DL1	1.82e-04	343	90	7	MM1059
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN	MYC ZNRF3 MTSS1 KAT6B TTC3	2.44e-04	162	90	5	M7002
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CLIP4 CD6 PIK3R1 SYTL2 KIR2DL1 KIR2DL3 KIR3DL1	6.51e-08	180	87	7	0a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CLIP4 CD6 PIK3R1 SYTL2 KIR2DL1 KIR2DL3 KIR3DL1	6.51e-08	180	87	7	1c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CLIP4 CD6 PIK3R1 SYTL2 KIR2DL1 KIR2DL3 KIR3DL1	6.51e-08	180	87	7	ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CLASP1 SYTL2 GPATCH8 KIR2DL3 KIR2DS4 KIR3DL1 PDZD4	1.16e-07	196	87	7	2849c8f06518c9523093b86167daea4c0b9eda73
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CLASP1 SYTL2 GPATCH8 KIR2DL3 KIR2DS4 KIR3DL1 PDZD4	1.16e-07	196	87	7	bd251231288c900b23d3a676ceec6ac07d228917
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CD6 PIK3R1 FOS SYTL2 PCNX1 SARAF KAT6B	1.21e-07	197	87	7	51340570667914bffec741c72a8d09cc46abb8e8
ToppCell	control-Lymphocytic-NK_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FURIN SYTL2 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 PDZD4	1.29e-07	199	87	7	8aca7775b3d34fd26c7b23ddb23f5f2df72684b0
ToppCell	ILEUM-inflamed-(1)_CD8_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PIK3R1 FOS SYTL2 PCNX1 SARAF SERINC5	1.82e-06	187	87	6	a77d7ae44f47410bd92fb3aa0f44dce891752b63
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CD6 GVINP1 PIK3R1 PCNX1 SARAF SERINC5	1.82e-06	187	87	6	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYTL2 KIR2DL1 GPATCH8 KIR2DL3 KIR2DS4 KIR3DL1	1.99e-06	190	87	6	1f890be1ac8613a098b271945f25a58c3c2530ab
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYTL2 KIR2DL1 GPATCH8 KIR2DL3 KIR2DS4 KIR3DL1	1.99e-06	190	87	6	d7cecf88451f736f8f3f6f4644504cf22846cd6e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYC CD6 PIK3R1 PCNX1 SARAF SERINC5	2.05e-06	191	87	6	9c747f8cc1cdce45e839b661d782e1e8cfb79578
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PIK3R1 SYTL2 SARAF KIR2DL1 KIR2DL3 KIR3DL1	2.18e-06	193	87	6	46f94a1062b098205e8ce3ed380c0202a4d97678
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PIK3R1 SYTL2 SARAF KIR2DL1 KIR2DL3 KIR3DL1	2.25e-06	194	87	6	5a859885c0f9b8554b0d203e371c70928ad4418f
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYC CD6 PIK3R1 NKTR SARAF SERINC5	2.25e-06	194	87	6	0b0042b6a356a49a059fb64a1e1abb25c82d48cf
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PIK3R1 SYTL2 SARAF KIR2DL1 KIR2DL3 KIR3DL1	2.25e-06	194	87	6	7d35ac70ba966eb1fee4197f7de6d6116326a442
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PIK3R1 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 CAP1	2.25e-06	194	87	6	ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PIK3R1 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 CAP1	2.25e-06	194	87	6	3a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	MYC CD6 PIK3R1 NKTR SARAF TTC3	2.31e-06	195	87	6	4bdedd924564a260841a9153604026b57487c83d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 PIK3R1 SYTL2 PCNX1 SARAF SERINC5	2.38e-06	196	87	6	e4c76e7ad68455e51fe93ce588bcec9383f8654b
ToppCell	Severe-NK\|Severe / Disease group and Cell class	FOS MTSS1 IRF7 KIR2DL1 KIR2DL3 KIR3DL1	2.38e-06	196	87	6	66130d38b67e51e2385de8a89227759fd137999c
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CD6 PIK3R1 FOS PCNX1 SARAF SERINC5	2.46e-06	197	87	6	b044833de12f2b9eb702155563cd8932bc16e0ef
ToppCell	Severe-NK\|World / Disease group and Cell class	FOS MTSS1 IRF7 KIR2DL1 KIR2DL3 KIR3DL1	2.46e-06	197	87	6	1e5fb79385657a467c2d9f942d8cafb8ef7826c9
ToppCell	Influenza_Severe-NK\|Influenza_Severe / Disease group and Cell class	PIK3R1 SYTL2 KIR2DL1 GPATCH8 KIR2DL3 KIR3DL1	2.46e-06	197	87	6	d0f58ee4c02573d214deb210bb7efd3d6118f267
ToppCell	severe-Lymphocytic-NK_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYTL2 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 PDZD4	2.46e-06	197	87	6	8bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PIK3R1 KIR2DL1 KAT6B KIR3DL1 PREX1 PDZD4	2.46e-06	197	87	6	52246d1354c4e2b13d48c878643edf843d2b50d2
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CD6 GVINP1 PCNX1 SARAF SERINC5 KAT6B	2.46e-06	197	87	6	076fc05b32200e0a8a1e35d03c295111468d92a9
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	KIR2DL1 GPATCH8 KIR2DL3 KIR3DL1 PREX1 CAP1	2.46e-06	197	87	6	879974aff3f887648a00b4659b46d9897c9eb467
ToppCell	severe-Lymphocytic-NK_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FURIN KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 PDZD4	2.53e-06	198	87	6	6ef22f33b43e9adceea11738e3cba0e8b59b4ec6
ToppCell	control-Lymphocytic-NK_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYTL2 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 PDZD4	2.53e-06	198	87	6	1c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN STARD9 NAV3 EMP1 PREX1 MEF2C	2.53e-06	198	87	6	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	MYC CD6 PIK3R1 SYTL2 IRF7 NKTR	2.60e-06	199	87	6	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-NK\|Influenza_Severe / Disease, condition lineage and cell class	PIK3R1 SYTL2 KIR2DL1 GPATCH8 KIR2DL3 KIR3DL1	2.68e-06	200	87	6	04ac14414d550b14dc46d682e7af9dd43982211a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ESPN TRAV5 CD6 PIK3R1 NKTR	1.66e-05	162	87	5	80317c4253bf8e897782e562f29835f181c65b98
ToppCell	390C-Lymphocytic-ILC\|390C / Donor, Lineage, Cell class and subclass (all cells)	TRAV5 CD6 PIK3R1 KIR2DL1 IGKV3-20	1.76e-05	164	87	5	b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRAV5 CD6 SYTL2 XPNPEP2 PDZD4	1.81e-05	165	87	5	5e7ee76f3dcddbd1b560bacd043f9001b0c18b5f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 POLR3E PIK3R1 PCNX1 NKTR	1.92e-05	167	87	5	83969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCell	severe_influenza-CD4+_CTL\|severe_influenza / disease group, cell group and cell class (v2)	CD6 PIK3R1 SYTL2 SARAF TRAV25	1.97e-05	168	87	5	50697fda702a09d9a621e9f79c2b52d53792dd2a
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16\|GI_small-bowel / Manually curated celltypes from each tissue	MTSS1 KIR2DL1 KIR2DL3 KIR3DL1 PDZD4	2.21e-05	172	87	5	701de463f85aaad3a4b36a0d5fbc416406620089
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TCP11L2 PIK3R1 KIR2DL1 KIR2DL3 KIR3DL1	2.27e-05	173	87	5	79d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRAV5 CD6 PDE8B SYTL2 PDZD4	2.47e-05	176	87	5	5914e7635474e7cf24d446bdb1423bc0807ee9c6
ToppCell	wk_15-18-Epithelial-PNS-Schwann_precursor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CLIP4 PCSK2 RALGPS1 PHOX2B PDZRN4	2.53e-05	177	87	5	5357359e6c2161a37f39a6b3b78449f5cbc327d1
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CLIP4 MACROD1 APOB ZDBF2 TEX15	2.67e-05	179	87	5	bf012825e88626e59cd1deebf67c2cd269ce4829
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_NK\|GI_small-bowel / Manually curated celltypes from each tissue	MTSS1 KIR2DL1 KIR2DL3 KIR3DL1 PDZD4	2.67e-05	179	87	5	535bdfdd990ba9ee3edc8f3ad15297f8fb5a266e
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOS SYTL2 SARAF TTC3 SUCO	2.90e-05	182	87	5	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOS SYTL2 SARAF TTC3 SUCO	2.90e-05	182	87	5	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	HMCN2 KALRN SYTL2 MEF2C PDZRN4	2.97e-05	183	87	5	818fd886e0188091310825f9145fa53328f2c979
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 PCNX1 NKTR SARAF SERINC5	3.05e-05	184	87	5	bd786db4dc4edae6d5cfc0b69901983dea19f729
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	SYTL2 MTSS1 PCNX1 KIR2DL2 PDZD4	3.05e-05	184	87	5	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	CLASP1 KIR2DL1 KIR2DL3 KIR3DL1 PREX1	3.13e-05	185	87	5	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MTSS1 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	3.21e-05	186	87	5	1590fe72badffc79f1d390deb3207116ac2281bb
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MTSS1 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	3.21e-05	186	87	5	e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 PIK3R1 FOS SARAF SERINC5	3.21e-05	186	87	5	c793a3d5709ad504c12fc3b2337746d90236d3ca
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	TRAV5 SYTL2 IRF7 KIR2DL1 KIR3DL1	3.30e-05	187	87	5	4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN STARD9 NAV3 PREX1 MEF2C	3.30e-05	187	87	5	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 PIK3R1 FOS SYTL2 PDZD4	3.30e-05	187	87	5	e1d6c1194476cf26969e405b0951796fed519f44
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-mature_NK_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SARAF KIR2DL1 KIR2DL3 KIR3DL1 TRAV25	3.30e-05	187	87	5	931f9d16ce541bb6979f7f179bcae21816721294
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	HMCN2 KALRN SYTL2 CLASP2 PDZRN4	3.38e-05	188	87	5	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYC CD6 NFATC1 FOS SERINC5	3.38e-05	188	87	5	939790f133eac9c12d08db6ddb5f08f5107844e3
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	MPZL1 PRICKLE2 CATSPERB ZDBF2 TTC3	3.47e-05	189	87	5	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 PIK3R1 SYTL2 SARAF SERINC5	3.47e-05	189	87	5	9ab77c6fcb573854da5922412f53d2168bda6b58
ToppCell	Bac-SEP-Lymphocyte-T_NK-CD4_TCM\|Bac-SEP / Disease, Lineage and Cell Type	MYC CD6 PIK3R1 SARAF SERINC5	3.47e-05	189	87	5	70f918dc208cd7ce8de9007729d8c5743c56c130
ToppCell	droplet-Limb_Muscle-nan-3m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP1 KALRN PDE8B PRICKLE2 DCBLD1	3.47e-05	189	87	5	16a4c92dd7a0d60f3691bd3130a091a9a54730f1
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	SYTL2 KIR2DL1 KIR2DL3 KIR3DL1 PDZD4	3.47e-05	189	87	5	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRAV5 SYTL2 IRF7 KIR2DL1 KIR3DL1	3.56e-05	190	87	5	b9182c84e44aa31684b5388cf3ef4fd1b9e51de4
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRAV5 SYTL2 IRF7 KIR2DL1 KIR3DL1	3.56e-05	190	87	5	88c092a5e78ccaddf406f8fff74376bb761b9790
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TRAV5 SYTL2 IRF7 KIR2DL1 KIR3DL1	3.56e-05	190	87	5	4b42a16902d7d1494f953cc88af1e761e76bdf2c
ToppCell	(1)_T_cells-(1)_T_CD4_fh\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	NFATC1 FOS DCBLD1 SARAF SERINC5	3.56e-05	190	87	5	120ca702600373c208a3d032fede0a040736e5cf
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYC CD6 PIK3R1 SARAF SERINC5	3.56e-05	190	87	5	1634a6044dce4e026a63976031a498c7460e3dce
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRAV5 SYTL2 IRF7 KIR2DL1 KIR3DL1	3.56e-05	190	87	5	9501f0995f3d52be90c02b1aa0c7d184bd788c16
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYC CD6 PIK3R1 SARAF SERINC5	3.56e-05	190	87	5	08813c2f9321b82f0ec66854bb7a383aa1171780
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 POLR3E PIK3R1 SARAF SERINC5	3.65e-05	191	87	5	9bb6a6b88f351217455765ba07a6acf11fda98f4
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CLASP1 STARD9 PIK3R1 FURIN KIR2DL2	3.65e-05	191	87	5	f1935e8f8467a2bc30588b7f2cc3b94e9c83b268
ToppCell	(1)_T_CD4_fh\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CD6 FOS DCBLD1 SARAF SERINC5	3.65e-05	191	87	5	66ddff9a99092cb384b9fb2a3ba95ddbebed67cc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3R1 FOS NAV3 EMP1 PDZRN4	3.65e-05	191	87	5	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CLASP1 STARD9 PIK3R1 FURIN KIR2DL2	3.65e-05	191	87	5	1161e465c50c2071764279e01cf08b1048cce0e3
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYC CD6 FOS SARAF SERINC5	3.65e-05	191	87	5	b53b490a8796e819edd3eb4a5a42b4499077b2d3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIK3R1 FOS PCNX1 SARAF SERINC5	3.65e-05	191	87	5	142f98cabf8737b28369315b3d7a0797ded88e03
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	PIK3R1 SYTL2 KIR2DL1 KIR2DL3 KIR3DL1	3.65e-05	191	87	5	f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CLASP1 STARD9 PIK3R1 FURIN KIR2DL2	3.65e-05	191	87	5	7a4fe96989f72159385270c712342ba3e1ca6fc3
ToppCell	Control-Lymphoid_T/NK-NK_CD56bright\|Control / Disease group, lineage and cell class	CLASP1 STARD9 PIK3R1 FURIN KIR2DL2	3.65e-05	191	87	5	e842f29bc03ed6734b2a7b975e7830a498f2743c
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CLASP1 STARD9 PIK3R1 FURIN KIR2DL2	3.65e-05	191	87	5	c023ca893ceae19b54967096f6e2588dc39fa268
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 NKTR SARAF SERINC5 TTC3	3.65e-05	191	87	5	696921a4f160b6b55698652488ed781e855e5e51
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo\|lymph-node_spleen / Manually curated celltypes from each tissue	PIK3R1 SYTL2 KIR2DL1 KIR2DL3 KIR3DL1	3.74e-05	192	87	5	4d72b9264ed62e0c08cde4078061b348253f6989
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 POLR3E PIK3R1 SARAF SERINC5	3.74e-05	192	87	5	1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	CD6 PCNX1 CLASP2 NKTR SERINC5	3.74e-05	192	87	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	ILEUM-non-inflamed-(1)_CD8_Trm\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PIK3R1 FOS PCNX1 NKTR SARAF	3.74e-05	192	87	5	a9f89043c97cd2b0ba165e69ee5681094410af37
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYC CD6 PIK3R1 SARAF SERINC5	3.74e-05	192	87	5	e07b6892276c81c1227e94ca942f6820d89a7ca3
ToppCell	COVID-19_Severe-CD4+_Tcm\|World / disease group, cell group and cell class	MYC CD6 PIK3R1 SARAF SERINC5	3.74e-05	192	87	5	3352f13a6e706991dcf3ec173587bb6aba36a385
ToppCell	remission-CD4+_T_naive\|World / disease stage, cell group and cell class	MYC CD6 SARAF SERINC5 TTC3	3.74e-05	192	87	5	4bd94ce876d70f93dbdfad1dcd09e1468213cf57
ToppCell	Healthy_donor-CD4+_Tcm\|World / disease group, cell group and cell class (v2)	CD6 POLR3E PIK3R1 SARAF SERINC5	3.74e-05	192	87	5	1603903454ba6bf65c8e13ede620e0b1e8fbd7ec
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN STARD9 NAV3 PREX1 MEF2C	3.74e-05	192	87	5	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3R1 FOS NAV3 CLASP2 MEF2C	3.83e-05	193	87	5	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	CV-Healthy\|CV / Virus stimulation, Condition and Cluster	CD6 MTSS1 IRF7 KIR2DL3 KIR3DL1	3.83e-05	193	87	5	0387ee691be9e3ea720ea67f6fa02eb6d58609e3
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYTL2 KIR2DL1 KIR3DL1 PREX1 PDZD4	3.83e-05	193	87	5	1cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYC CD6 PIK3R1 SARAF SERINC5	3.93e-05	194	87	5	929b97eb0a4a88cd566f832d4959b8b8a34c46b4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYC CD6 PIK3R1 SARAF SERINC5	3.93e-05	194	87	5	4bcbea5dc0c91c51fbb6b0f7de1e47010c62812a
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	MPZL1 PRICKLE2 CATSPERB ZDBF2 TTC3	3.93e-05	194	87	5	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	COVID-19_Mild-Lymphoid_T/NK-CD4+_Tcm\|COVID-19_Mild / Disease group, lineage and cell class	MYC CD6 PIK3R1 SARAF SERINC5	3.93e-05	194	87	5	0aad8c7f356d54346af764e0cc4edce89c6daabb
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	PIK3R1 SYTL2 KIR2DL3 KIR3DL1 PDZD4	3.93e-05	194	87	5	ecdfc27d06e363fb23f0309f26ef6404a89f14ec
Computational	Neighborhood of IL2RB	KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1	7.37e-05	46	53	4	GNF2_IL2RB
Drug	D-Au	STK36 MTSS1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	1.65e-11	77	88	9	CID000277822
Drug	Aa1	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	3.31e-08	83	88	7	CID009549188
Drug	ecopipam	DRD1 DRD5 FOS	5.58e-08	3	88	3	ctd:C058081
Drug	pristane	POLR3E IRF7 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KAT6B KIR2DS5	1.34e-07	152	88	8	CID000015979
Drug	A 68930	DRD1 DRD5 FOS	5.55e-07	5	88	3	ctd:C065380
Drug	dihydrexidine	DRD1 DRD5 FOS	5.55e-07	5	88	3	ctd:C061532
Drug	Lysergol [602-85-7]; Down 200; 15.8uM; PC3; HT_HG-U133A	CD6 FURIN NAV3 CLASP2 NKTR BBS9 TGS1 RUSC2	9.69e-07	197	88	8	6621_DN
Drug	LEK-8829	DRD1 DRD5 FOS	3.08e-06	8	88	3	CID000164460
Drug	Sch 23982	DRD1 DRD5 KIR3DL1	3.08e-06	8	88	3	CID000119353
Drug	PAOPA	DRD1 DRD5 FOS	4.61e-06	9	88	3	CID000129409
Drug	AC1L1AQK	KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 PDZD4	6.86e-06	119	88	6	CID000001105
Drug	AC1L1CM5	DRD1 DRD5 FOS	9.00e-06	11	88	3	CID000001961
Drug	Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	PDE8B FOS SOX30 PCNX1 TEX15 SEMA4G RUSC2	9.06e-06	190	88	7	6825_UP
Drug	1c88	FOS KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5	9.53e-06	126	88	6	CID000444766
Drug	Glimepiride [93479-97-1]; Down 200; 8.2uM; PC3; HT_HG-U133A	CD6 PDE8B PIK3R1 NAV3 PCNX1 BBS9 TGS1	1.26e-05	200	88	7	6628_DN
Drug	columbamine	DRD1 DRD5	1.48e-05	2	88	2	CID000072309
Drug	dehydrocorybulbine	DRD1 DRD5	1.48e-05	2	88	2	CID005316439
Drug	zelandopam	DRD1 DRD5	1.48e-05	2	88	2	CID003078104
Drug	tetrahydrocolumbamine	DRD1 DRD5	1.48e-05	2	88	2	CID000010220
Drug	CY 208-243	DRD1 DRD5 FOS	1.97e-05	14	88	3	CID000058144
Drug	DNTB	MYC DRD5 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5	2.08e-05	216	88	7	CID000015325
Drug	1xa5	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4	3.06e-05	93	88	5	CID000157684
Drug	Magnetite Nanoparticles	MYC EPS15 PER2 ZFYVE16 PDE8B STARD9 PIK3R1 FOS MTSS1 IRF7 NKTR TTC3 NCKAP5L BBS9 MEF2C SEMA4G	3.75e-05	1310	88	16	ctd:D058185
Drug	Theophylline	MYC EPS15 DRD5 FOS PRKAA1 DCBLD1 IRF7 GPATCH8 KIR2DL3 TTC3	3.93e-05	532	88	10	ctd:D013806
Drug	PACPX	DRD1 DRD5 POLR3E	4.37e-05	18	88	3	CID000092411
Drug	2,4,6-trimethylpyrylium	APOB KAT6B	4.42e-05	3	88	2	CID000135854
Drug	menthol glucuronide	APOB SPEN	4.42e-05	3	88	2	CID000133208
Drug	U-99363E	DRD1 DRD5	4.42e-05	3	88	2	CID000133107
Drug	SB 222200	DRD1 FOS	4.42e-05	3	88	2	ctd:C109112
Drug	phenylalanyl-prolyl-arginine methyl chloride	MYC FOS	4.42e-05	3	88	2	ctd:C020924
Drug	AC1LR3WA	DRD1 DRD5	4.42e-05	3	88	2	CID001361946
Drug	PREPARATIONS	STK36 APOB	4.42e-05	3	88	2	CID000019670
Drug	Berupipam	DRD1 DRD5	4.42e-05	3	88	2	CID000066002
Drug	carphenazine	DRD1 DRD5	4.42e-05	3	88	2	CID000018104
Drug	Carphenazine	DRD1 DRD5	4.42e-05	3	88	2	DB01038
Drug	glycoluril	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	5.28e-05	53	88	4	CID000062347
Drug	Norepinephrine	MYC PCSK2 DRD1 PER2 FOS FURIN	5.35e-05	171	88	6	ctd:D009638
Drug	Fumadil B	DRD1 DRD5 POLR3E XPNPEP2	5.68e-05	54	88	4	CID000003430
Drug	AC1L1KWW	DRD1 DRD5 KIR3DL1	6.06e-05	20	88	3	CID000005688
Drug	Ab-9	KIR2DL2 KIR2DL3 KIR3DL1	7.06e-05	21	88	3	CID006540280
Drug	BP 897	DRD1 DRD5 FOS	8.15e-05	22	88	3	CID003038494
Drug	ferric oxide	PER2 FOS IRF7 NCKAP5L MEF2C RUSC2	8.53e-05	186	88	6	ctd:C000499
Drug	estradiol-16	MYC FOS	8.82e-05	4	88	2	ctd:C063035
Drug	U 101958	DRD1 DRD5	8.82e-05	4	88	2	CID005311492
Drug	dimethocaine	DRD1 DRD5	8.82e-05	4	88	2	CID000007177
Drug	MK-458	DRD1 DRD5	8.82e-05	4	88	2	CID000057532
Drug	SCH 40853	DRD1 DRD5	8.82e-05	4	88	2	CID003035575
Drug	DK-118	DRD1 DRD5	8.82e-05	4	88	2	CID000145953
Drug	Reserpine	MYC PCSK2 DRD1 FOS FURIN	9.93e-05	119	88	5	ctd:D012110
Drug	Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	ZFYVE16 PDE8B MPZL1 MTSS1 BBS9 MEF2C	1.02e-04	192	88	6	1153_UP
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	PER2 NFATC1 NKTR EMP1 TGS1 RUSC2	1.04e-04	193	88	6	1148_UP
Drug	TL-99	DRD1 DRD5 TGS1	1.06e-04	24	88	3	CID000122132
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A	CD6 NAV3 PCNX1 BBS9 SEMA4G TGS1	1.11e-04	195	88	6	6626_DN
Drug	canola oil	MYC FOS IRF7 APOB PREX1	1.12e-04	122	88	5	ctd:C061996
Drug	Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A	DRD1 CD6 PER2 PIK3R1 RALGPS1 NKTR	1.14e-04	196	88	6	4689_DN
Drug	Dimethadione [695-53-4]; Down 200; 31uM; MCF7; HT_HG-U133A	CLIP4 CD6 FURIN EMP1 BAHCC1 RUSC2	1.17e-04	197	88	6	5668_DN
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; PC3; HT_HG-U133A	RALGPS1 PCNX1 TEX15 MEF2C SEMA4G TGS1	1.24e-04	199	88	6	4484_DN
Drug	rotenone; Down 200; 1uM; PC3; HT_HG-U133A	SOX30 MTSS1 PCNX1 EMP1 MEF2C TGS1	1.24e-04	199	88	6	5920_DN
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	CLIP4 CD6 NFATC1 SOX30 MTSS1 PCNX1	1.27e-04	200	88	6	4820_UP
Drug	AC1L71LN	PCSK2 DRD1 DRD5 FURIN MTSS1	1.40e-04	128	88	5	CID000327966
Drug	SCH 24518	DRD1 DRD5	1.47e-04	5	88	2	CID000146265
Drug	tilozepine	DRD1 DRD5	1.47e-04	5	88	2	CID000172286
Drug	C9H11N3O2	DRD1 DRD5	1.47e-04	5	88	2	CID000123703
Drug	SKF 77434	DRD1 DRD5	1.47e-04	5	88	2	CID000001241
Drug	Levodopa	DRD1 DRD5	1.47e-04	5	88	2	DB01235
Drug	corydaline	DRD1 DRD5	1.47e-04	5	88	2	CID000101301
Drug	dopamine quinone	PCSK2 FURIN	1.47e-04	5	88	2	ctd:C104705
Drug	dazopride	DRD1 DRD5	1.47e-04	5	88	2	CID000054801
Drug	Fenoldopam	DRD1 DRD5	1.47e-04	5	88	2	DB00800
Drug	azapride	DRD1 DRD5	1.47e-04	5	88	2	CID003036441
Drug	DH97	DRD1 DRD5	1.47e-04	5	88	2	CID003467177
Drug	AMMTC	DRD1 DRD5	1.47e-04	5	88	2	CID005311004
Drug	stepholidine	DRD1 FOS	1.47e-04	5	88	2	ctd:C010513
Drug	2-di-n-propylaminoindan	DRD1 DRD5	1.47e-04	5	88	2	CID000130402
Drug	mezilamine	DRD1 DRD5	1.47e-04	5	88	2	CID000068678
Drug	NNC-687	DRD1 DRD5	1.47e-04	5	88	2	CID000164252
Drug	proterguride	DRD1 DRD5	1.47e-04	5	88	2	CID000071999
Drug	NO 756	DRD1 DRD5	1.47e-04	5	88	2	CID000129967
Drug	SKF 82957	DRD1 DRD5	1.47e-04	5	88	2	CID000130844
Drug	SKF85174	DRD1 DRD5	1.47e-04	5	88	2	CID000132435
Drug	l-CSL	DRD1 DRD5	1.47e-04	5	88	2	CID006918538
Drug	3-iodobenzamide	DRD1 DRD5	1.47e-04	5	88	2	CID000202425
Drug	piquindone	DRD1 DRD5	1.47e-04	5	88	2	CID000121903
Drug	Apomorphine	DRD1 FOS FURIN	1.53e-04	27	88	3	ctd:D001058
Drug	AC1ODVCS	PCSK2 KIR2DL2 KIR2DL3	2.10e-04	30	88	3	CID000111104
Drug	6-carboxyfluorescein diacetate	KIR2DL1 KIR2DL2 KIR2DL3	2.10e-04	30	88	3	CID000151095
Drug	pyrazole-3	DRD1 DRD5	2.19e-04	6	88	2	CID000354929
Drug	Zuclopenthixol	DRD1 DRD5	2.19e-04	6	88	2	DB01624
Drug	A66359	DRD1 DRD5	2.19e-04	6	88	2	CID000173657
Drug	CI-943	DRD1 DRD5	2.19e-04	6	88	2	CID000146009
Drug	propylbutyldopamine	DRD1 DRD5	2.19e-04	6	88	2	CID000156067
Drug	pyro-Glu-His-Gly	MYC FOS	2.19e-04	6	88	2	CID003918406
Drug	LON-954	DRD1 DRD5	2.19e-04	6	88	2	CID006441097
Drug	3-deazaadenosine	MYC APOB	2.19e-04	6	88	2	ctd:C018258
Drug	7-hydroxyamoxapine	DRD1 DRD5	2.19e-04	6	88	2	CID000162242
Drug	BAM-1110	DRD1 DRD5	2.19e-04	6	88	2	CID003064755
Drug	AC1MI81B	DRD1 DRD5	2.19e-04	6	88	2	CID003039938
Drug	HW-165	DRD1 DRD5	2.19e-04	6	88	2	CID000125677
Drug	isoliensinine	MYC FOS	2.19e-04	6	88	2	CID005274591
Drug	2'-ISP	DRD1 DRD5	2.19e-04	6	88	2	CID000128389
Disease	level of killer cell immunoglobulin-like receptor 2DS2 in blood serum	KIR2DL1 KIR2DL3	2.51e-05	3	86	2	OBA_2042107
Disease	coronary artery calcification	CCDC195 STARD9 MTSS1 PRICKLE2 NAV3 APOB EMP1 MEF2C	5.16e-05	450	86	8	EFO_0004723
Disease	household income	KALRN PIK3R1 PCNX1 TEX15 EMP1 MEF2C	2.68e-04	304	86	6	EFO_0009695
Disease	acquired immunodeficiency syndrome (is_implicated_in)	KIR2DL1 KIR3DS1	2.98e-04	9	86	2	DOID:635 (is_implicated_in)
Disease	killer cell immunoglobulin-like receptor 2DL4 measurement	SLFN14 KIR2DS4	5.44e-04	12	86	2	EFO_0008197
Disease	African Burkitt's lymphoma	MYC PIK3R1	8.60e-04	15	86	2	C0343640
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	KIR2DL1 KIR2DL3	8.60e-04	15	86	2	EFO_0801746
Disease	Burkitt Leukemia	MYC PIK3R1	8.60e-04	15	86	2	C4721444
Disease	preeclampsia, hypertension, pregnancy-induced	FURIN PREX1	9.81e-04	16	86	2	EFO_0000668, MONDO_0024664
Disease	Colorectal Carcinoma	MYC PCSK2 CACUL1 NFATC1 KALRN APOB FBXO30 PDZRN4	1.02e-03	702	86	8	C0009402
Disease	Antihypertensive use measurement	ZNRF3 PIK3R1 RALGPS1 FURIN PREX1	1.08e-03	265	86	5	EFO_0009927
Disease	brain measurement, neuroimaging measurement	RALGPS1 NAV3 CATSPERB NCKAP5 GPATCH8 BBS9 BAHCC1	1.14e-03	550	86	7	EFO_0004346, EFO_0004464
Disease	Manic Disorder	DRD1 DRD5 STARD9	1.18e-03	71	86	3	C0024713
Disease	Carcinomatosis	MYC PIK3R1 FURIN MPZL1	1.34e-03	163	86	4	C0205699
Disease	Carcinoma, Spindle-Cell	MYC PIK3R1 FURIN MPZL1	1.34e-03	163	86	4	C0205697
Disease	Undifferentiated carcinoma	MYC PIK3R1 FURIN MPZL1	1.34e-03	163	86	4	C0205698
Disease	Anaplastic carcinoma	MYC PIK3R1 FURIN MPZL1	1.34e-03	163	86	4	C0205696
Disease	Carcinoma	MYC PIK3R1 FURIN MPZL1	1.37e-03	164	86	4	C0007097
Disease	unipolar depression, response to bupropion, mood disorder	CCDC195 NAV3	1.39e-03	19	86	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	triglyceride measurement, body mass index	STK36 MACROD1	1.39e-03	19	86	2	EFO_0004340, EFO_0004530
Disease	anti-Mullerian hormone measurement	ZNRF3 MEF2C	1.54e-03	20	86	2	EFO_0004769
Disease	Manic	DRD1 DRD5 STARD9	1.55e-03	78	86	3	C0338831
Disease	Depression, Bipolar	DRD1 DRD5 STARD9	1.61e-03	79	86	3	C0005587
Disease	blood pressure	PREX1 MEF2C	1.87e-03	22	86	2	EFO_0004325
Disease	depressive disorder (implicated_via_orthology)	DRD1 DRD5	1.87e-03	22	86	2	DOID:1596 (implicated_via_orthology)
Disease	cardiovascular disease	PIK3R1 MACROD1 PCNX1 APOB PREX1 BAHCC1	2.21e-03	457	86	6	EFO_0000319
Disease	malaria (is_implicated_in)	KIR3DL1 KIR3DS1	2.22e-03	24	86	2	DOID:12365 (is_implicated_in)
Disease	HMG CoA reductase inhibitor use measurement	FURIN MACROD1 PCNX1 APOB	2.30e-03	189	86	4	EFO_0009932
Disease	blood rubidium measurement	NCKAP5 PREX1	2.61e-03	26	86	2	EFO_0021529

Protein segments in the cluster

Peptide	Gene	Start	Entry
GDSSVINCTYTDSSS	TRAV5	36	A0A0B4J249
SSLCSSDNEDSSYSS	BAHCC1	2366	Q9P281
NRTLSESSSCFYSQE	CATSPERB	321	Q9H7T0
ETQQSSSENSYFCST	GVINP1	276	Q7Z2Y8
SCSYESASRSSLFAQ	CAP1	246	Q01518
CDSSLSRTYAISSSV	DRD1	186	P21728
SSCSSTSSLEHRQSY	CLIP4	426	Q8N3C7
GDELAYNSSSACASS	CACUL1	351	Q86Y37
SDKDSSSAYNTAESC	PDZRN4	731	Q6ZMN7
SSSSDSLEGQSCDYA	RALGPS1	21	Q5JS13
NCDSSLNRTYAISSS	DRD5	216	P21918
AGESVTLSCSSRSSY	KIR2DS2	141	P43631
SRSFQCSVCNSSFSS	PRDM5	231	Q9NQX1
QNSCSYSNLTSSSLT	KAT6B	1701	Q8WYB5
YSNLTSSSLTQSSCA	KAT6B	1706	Q8WYB5
NSESSTSSGEDYCNS	CD6	561	P30203
NISCSDSLSYASEDA	EMP1	46	P54849
AGESVTLSCSSRSSY	KIR2DL2	141	P43627
AGENVTLSCSSRSSY	KIR2DS4	141	P43632
SESLSDSLYDSLSSC	NCKAP5L	1316	Q9HCH0
FNADYEASSSRCSSA	FOS	6	P01100
AGESVTLSCSSRSSY	KIR2DL3	141	P43628
STADSGDYSCTARNA	HMCN2	3656	Q8NDA2
TLSNYDSCSSSHSSI	ESPN	376	B1AK53
RYSISSSVCSSAVND	CCDC195	86	A0A1B0GUA6
AGESVTLSCSSRSSY	KIR3DL1	236	P43629
QSSTDISDTCAVSYS	FAM135A	1046	Q9P2D6
SRRSYSSSSDASSDQ	GPATCH8	866	Q9UKJ3
SSSSDASSDQSCYSR	GPATCH8	871	Q9UKJ3
SDDDYSLSCSQSRSR	GPATCH8	931	Q9UKJ3
ESVASLTSQCSYSST	PER2	661	O15055
STESYCSGTDRDTNS	PCNX1	381	Q96RV3
CSGTDRDTNSTVSSY	PCNX1	386	Q96RV3
RDSLQCSSGYSTQTT	MTSS1	496	O43312
DSTSAYNTGESCRST	PDZD4	466	Q76G19
YCRDSDESSSPRQTT	PDE8B	16	O95263
AANYSSTQSCDSEST	NAV3	2356	Q8IVL0
NYLILCCSAATSSSS	FRYL	866	O94915
NSSATYTVSSCDSGE	KALRN	2516	O60229
SLSSRSCNSEASSYE	NFATC1	176	O95644
VDSLSSCSSSYDGSD	MEF2C	421	Q06413
SSLSLCLSSANSLYD	IRF7	476	Q92985
CSTLYRTQSSSNLAE	PIK3R1	146	P27986
SKRDYTGCSTSESLS	MPZL1	196	O95297
YSSRTDSFLTVSSCQ	BBS9	186	Q3SYG4
AGESVTLSCSSRSSY	KIR2DS5	141	Q14953
DSDSTYCSSTVFLDT	PASD1	261	Q8IV76
STCSSSSESDNEGYF	PRICKLE2	776	Q7Z3G6
CTSGAYSNASSTDSA	APOB	976	P04114
EACSSTLATTYSSGN	FURIN	331	P09958
DSLISACRSDSFYSS	HOXD10	16	P28358
SASQAAELRSCYLSS	MACROD1	236	Q9BQ69
DSACSVDYSSSCLSS	MAPKBP1	996	O60336
LSCRASQSVSSSYLA	IGKV3-20	41	P01619
LSCRASQSVSSSYLT	IGKV3-7	41	A0A075B6H7
NGATDYCSLSTSSSE	EPS15	521	P42566
YCSLSTSSSETANLN	EPS15	526	P42566
SQTCASDYLLFTSSS	DCBLD1	91	Q8N8Z6
SSDLLCDLNTSSYDT	FBXO30	266	Q8TB52
TFCSSQTTSNTSRYA	POLR3E	101	Q9NVU0
AGENVTLSCSSRSSY	KIR2DL1	141	P43626
AGENVTLSCSSRSSY	KIR2DS1	141	Q14954
RCSSTSSQSEAADQS	RUSC2	251	Q8N2Y8
NSSSSSTDSETLRYN	SYTL2	276	Q9HCH5
DYNSCLISSASSARK	SLFN14	361	P0C7P3
SYSSSRSDLYSSCDR	RBMXL1	326	Q96E39
SDYECSRQSFASDSS	TCP11L2	31	Q8N4U5
SYSVCSNSDTKTRTA	SARAF	316	Q96BY9
SELSLSSTCSEYSSG	NCKAP5	336	O14513
KYSDHSQCSRSSSYT	NKTR	731	P30414
SQCSRSSSYTSISSD	NKTR	736	P30414
CSTSSLYLQDLSAAA	MYC	171	P01106
AGESVTLSCSSRSSY	KIR3DS1	236	Q14943
SECNSNRDSVLSYTS	PREX1	1171	Q8TCU6
SDTDSNYSLDSLSCV	STARD9	1101	Q9P2P6
SLLSSCSDSVALYSF	STK36	481	Q9NRP7
SFRDYSSECTHSENS	SOX30	671	O94993
SVSNYRSCQRSDSDA	PRKAA1	496	Q13131
DANSDASSVCSERSY	CLASP1	826	Q7Z460
NSDASSACSERSYSS	CLASP2	626	O75122
SCITDSLRSQGYNSS	SEMA4G	376	Q9NTN9
YSRSSDRSGSCSSLS	SPEN	756	Q96T58
LYSCLTSTTRSSSDA	SERINC5	326	Q86VE9
VTSTSEYCSCVSSSR	FAM170A	51	A1A519
SYESSSSETNFDCDA	ZDBF2	486	Q9HCK1
RSYDCSSSELTFDSD	ZDBF2	741	Q9HCK1
LSTEDYTTCFSSRNF	TTC3	851	P53804
RVCCKESSSASASSY	SUCO	26	Q9UBS9
SSETSSQSEESYFCG	SUCO	1166	Q9UBS9
GSCSTFRSSLSSDYD	ZNRF3	581	Q9ULT6
DFTTYCNSSTTLSNI	TRAV25	36	A0A0B4J276
RFSSETLSYLNSSCT	XPNPEP2	281	O43895
TFDASQSCDTDTYTS	TGS1	261	Q96RS0
SSYNIETAHDSSNCS	TEX15	401	Q9BXT5
TISSSTQRSYNTCCS	TMEM134	96	Q9H6X4
LASAYADFSSCSQAS	PHOX2B	26	Q99453
FRHASYSSTTSDCET	WNK4	571	Q96J92
YDSNHCSVSSELASS	ZFYVE16	36	Q7Z3T8
CASSETSYGTNESSL	ZFYVE16	66	Q7Z3T8
ALYDESCSSTLASTF	PCSK2	341	P16519